Home
IDYA
IDYA News

Latest IDEAYA Biosciences Inc. (IDYA) News on July 26, 2024

How Much Upside is Left in IDEAYA Biosciences (IDYA)? Wall Street Analysts Think 32.97%

Zacks

3 days ago

How Much Upside is Left in IDEAYA Biosciences (IDYA)? Wall Street Analysts Think 32.97%

MT Newswires

10 days ago

Wedbush Cuts Price Target on IDEAYA Biosciences to $54 From $56, Maintains Outperform Rating

Industry Analysts Just Made A Meaningful Upgrade To Their IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Revenue Forecasts

Simply Wall St.

11 days ago

Industry Analysts Just Made A Meaningful Upgrade To Their IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Revenue Forecasts

MT Newswires

14 days ago

JPMorgan Raises Price Target on IDEAYA Biosciences to $69 From $65, Maintains Overweight Rating

IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

PR Newswire

15 days ago

IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Biotech Stock Roundup: KYMR, IDYA, QURE Soar on Study Data, HLVX Tanks on Study Failure

Zacks

15 days ago

Biotech Stock Roundup: KYMR, IDYA, QURE Soar on Study Data, HLVX Tanks on Study Failure

MT Newswires

16 days ago

RBC Raises Price Target on IDEAYA Biosciences to $61 From $53, Keeps Outperform, Speculative Risk

MT Newswires

17 days ago

IDEAYA Biosciences Prices $263 Million Public Offering

IDEAYA Announces Pricing of Public Offering

PR Newswire

17 days ago

IDEAYA Announces Pricing of Public Offering

MT Newswires

17 days ago

IDEAYA Biosciences Plans to Sell Shares, Pre-Funded Warrants

IDEAYA Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

PR Newswire

17 days ago

IDEAYA Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

IDEAYA (IDYA) Up on Upbeat Phase II Bladder & Lung Cancer Data

Zacks

17 days ago

IDEAYA (IDYA) Up on Upbeat Phase II Bladder & Lung Cancer Data

Company News for July 9, 2024

Zacks

17 days ago

Company News for July 9, 2024

Strength Seen in IDEAYA Biosciences (IDYA): Can Its 15.3% Jump Turn into More Strength?

Zacks

18 days ago

Strength Seen in IDEAYA Biosciences (IDYA): Can Its 15.3% Jump Turn into More Strength?

IDEAYA Biosciences reports positive data from Phase II trial of cancer treatment

Clinical Trials Arena

18 days ago

IDEAYA Biosciences reports positive data from Phase II trial of cancer treatment

Top Stock Movers Now: Intel, Corning, SolarEdge, and More

Investopedia

18 days ago

Top Stock Movers Now: Intel, Corning, SolarEdge, and More

IDEAYA Biosciences Soars on Cancer Drug Study Results

Investopedia

18 days ago

IDEAYA Biosciences Soars on Cancer Drug Study Results

MT Newswires

18 days ago

Wedbush Raises Price Target on IDEAYA Biosciences to $56 From $52, Maintains Outperform Rating

Why Ideaya Biosciences Just Made Its Most Bullish Move Since March

Investor's Business Daily

18 days ago

Why Ideaya Biosciences Just Made Its Most Bullish Move Since March

MT Newswires

19 days ago

Ideaya Biosciences Reports Positive Results for Potential Non-Small Cell Lung Cancer Treatment -- Shares Rise Pre-Bell

IDEAYA Announces Positive Interim Phase 2 Monotherapy Expansion Data for IDE397 a Potential First-in-Class MAT2A Inhibitor in MTAP-Deletion Urothelial and Lung Cancer

PR Newswire

19 days ago

IDEAYA Announces Positive Interim Phase 2 Monotherapy Expansion Data for IDE397 a Potential First-in-Class MAT2A Inhibitor in MTAP-Deletion Urothelial and Lung Cancer

MT Newswires

19 days ago

Mizuho Securities Initiates IDEAYA Biosciences at Outperform With $50 Price Target

IDEAYA Announces Investor Webcast to Report Clinical Data Update for IDE397 Phase 2 Monotherapy Expansion Dose in MTAP-Deletion Urothelial and Lung Cancer on Monday, July 8, 2024

PR Newswire

21 days ago

IDEAYA Announces Investor Webcast to Report Clinical Data Update for IDE397 Phase 2 Monotherapy Expansion Dose in MTAP-Deletion Urothelial and Lung Cancer on Monday, July 8, 2024

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

PR Newswire

a month ago

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

IDEAYA Biosciences initiates subject dosing in Phase I bladder cancer trial

Clinical Trials Arena

a month ago

IDEAYA Biosciences initiates subject dosing in Phase I bladder cancer trial

IDEAYA Biosciences Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE397 and Trodelvy® Combination in MTAP-Deletion Bladder Cancer

PR Newswire

a month ago

IDEAYA Biosciences Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE397 and Trodelvy® Combination in MTAP-Deletion Bladder Cancer

IDEAYA Biosciences Announces Clinical Program Updates for IDE397 a Potential First-in-Class Phase 2 MAT2A Inhibitor Targeting MTAP-Deletion Solid Tumors

PR Newswire

a month ago

IDEAYA Biosciences Announces Clinical Program Updates for IDE397 a Potential First-in-Class Phase 2 MAT2A Inhibitor Targeting MTAP-Deletion Solid Tumors

Investors in IDEAYA Biosciences (NASDAQ:IDYA) have seen impressive returns of 277% over the past five years

Simply Wall St.

a month ago

Investors in IDEAYA Biosciences (NASDAQ:IDYA) have seen impressive returns of 277% over the past five years

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Business Wire

2 months ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

GlobeNewswire

2 months ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23

GlobeNewswire

2 months ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Simply Wall St.

2 months ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

Reuters

2 months ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

AFP

2 months ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Enduring role of 'treasuring the past' hailed

PR Newswire

2 months ago

Enduring role of 'treasuring the past' hailed

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

GlobeNewswire

2 months ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

MT Newswires

2 months ago

Stifel Adjusts Price Target on IDEAYA Biosciences to $63 From $55, Maintains Buy Rating

IDEAYA Announces Results for Darovasertib Phase 2 IST in Neoadjuvant Uveal Melanoma at ASCO and Clinical Update for Phase 2 Company-Sponsored Neoadjuvant Study

PR Newswire

2 months ago

IDEAYA Announces Results for Darovasertib Phase 2 IST in Neoadjuvant Uveal Melanoma at ASCO and Clinical Update for Phase 2 Company-Sponsored Neoadjuvant Study

MT Newswires

2 months ago

Ideaya Biosciences Insider Sold Shares Worth $1,032,884, According to a Recent SEC Filing

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

PR Newswire

2 months ago

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

IDEAYA Biosciences to Participate in Upcoming June 2024 Investor Relations Events

PR Newswire

2 months ago

IDEAYA Biosciences to Participate in Upcoming June 2024 Investor Relations Events

IDEAYA Biosciences Appoints Daniel A. Simon as Chief Business Officer to Lead Corporate Strategy and Business Development

PR Newswire

2 months ago

IDEAYA Biosciences Appoints Daniel A. Simon as Chief Business Officer to Lead Corporate Strategy and Business Development

/C O R R E C T I O N -- IDEAYA Biosciences, Inc./

PR Newswire

2 months ago

/C O R R E C T I O N -- IDEAYA Biosciences, Inc./

MT Newswires

2 months ago

Ideaya Biosciences Insider Sold Shares Worth $7,397,291, According to a Recent SEC Filing

MT Newswires

3 months ago

Oppenheimer Adjusts IDEAYA Biosciences Price Target to $53 From $50, Maintains Outperform Rating

IDEAYA Biosciences First Quarter 2024 Earnings: US$0.53 loss per share (vs US$0.49 loss in 1Q 2023)

Simply Wall St.

3 months ago

IDEAYA Biosciences First Quarter 2024 Earnings: US$0.53 loss per share (vs US$0.49 loss in 1Q 2023)

MT Newswires

3 months ago

IDEAYA Biosciences Shares Fall After Q1 Loss

GuruFocus.com

3 months ago

IDEAYA Biosciences Inc (IDYA) Reports Q1 2024 Earnings: Financial and Strategic Developments

IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

PR Newswire

3 months ago

IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

IDEAYA Biosciences to Participate in Upcoming May 2024 Investor Relations Event

PR Newswire

3 months ago

IDEAYA Biosciences to Participate in Upcoming May 2024 Investor Relations Event

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

PR Newswire

3 months ago

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma Phase 2 Investigator Sponsored Study

PR Newswire

3 months ago

IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma Phase 2 Investigator Sponsored Study

IDEAYA Biosciences Announces Selection of Move-Forward Phase 2 Expansion Dose for IDE397 Monotherapy in MTAP-Deletion Squamous Non-Small Cell Lung Cancer

PR Newswire

3 months ago

IDEAYA Biosciences Announces Selection of Move-Forward Phase 2 Expansion Dose for IDE397 Monotherapy in MTAP-Deletion Squamous Non-Small Cell Lung Cancer

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

PR Newswire

4 months ago

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

IDEAYA Biosciences to Participate in Upcoming April 2024 Investor Relations Event

PR Newswire

4 months ago

IDEAYA Biosciences to Participate in Upcoming April 2024 Investor Relations Event

TipRanks’ ‘Perfect 10’ List: These 3 Top-Scoring Stocks Are Sending a Bullish Signal

TipRanks

4 months ago

TipRanks’ ‘Perfect 10’ List: These 3 Top-Scoring Stocks Are Sending a Bullish Signal

IDEAYA Announces Clinical Collaboration to Evaluate IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer

PR Newswire

5 months ago

IDEAYA Announces Clinical Collaboration to Evaluate IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer

IDEAYA Biosciences to Participate in Upcoming March 2024 Investor Relations Events

PR Newswire

5 months ago

IDEAYA Biosciences to Participate in Upcoming March 2024 Investor Relations Events

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Analysts Are Pretty Bullish On The Stock After Recent Results

Simply Wall St.

5 months ago

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Analysts Are Pretty Bullish On The Stock After Recent Results

IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

PR Newswire

5 months ago

IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

IDEAYA Biosciences Inc CEO Yujiro Hata Sells 99,372 Shares

GuruFocus.com

5 months ago

IDEAYA Biosciences Inc CEO Yujiro Hata Sells 99,372 Shares

Mortgage Rates Tick Down

GlobeNewswire

6 months ago

Mortgage Rates Tick Down

Revvity (RVTY) Q4 Earnings Top, EPS View Above Expectation

Zacks

6 months ago

Revvity (RVTY) Q4 Earnings Top, EPS View Above Expectation

IDEAYA Biosciences to Participate in Upcoming February 2024 Investor Relations Events

PR Newswire

6 months ago

IDEAYA Biosciences to Participate in Upcoming February 2024 Investor Relations Events

Why Medical Properties Trust Stock Tumbled on Tuesday

Motley Fool

6 months ago

Why Medical Properties Trust Stock Tumbled on Tuesday

Symbotic Inc. (SYM) Gains As Market Dips: What You Should Know

Zacks

6 months ago

Symbotic Inc. (SYM) Gains As Market Dips: What You Should Know

Is It Too Late To Consider Buying BlackLine, Inc. (NASDAQ:BL)?

Simply Wall St.

6 months ago

Is It Too Late To Consider Buying BlackLine, Inc. (NASDAQ:BL)?

12 Stocks with Potential to Explode

Insider Monkey

6 months ago

12 Stocks with Potential to Explode

Permian Resources Announces Portfolio Optimization Transactions

Business Wire

6 months ago

Permian Resources Announces Portfolio Optimization Transactions

Essential Properties Realty Trust, Inc. Announces 2023 Dividend Tax Status

Business Wire

6 months ago

Essential Properties Realty Trust, Inc. Announces 2023 Dividend Tax Status

GlobeNewswire

6 months ago

Simplicity Group Unveils WeDYOR: Transforming Due Diligence for Crypto Investments

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30

CNW Group

6 months ago

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30

Automotive Telematics Market to Exceed USD 34.52 billion by 2031 | According to Transparency Market Research Analysis

GlobeNewswire

6 months ago

Automotive Telematics Market to Exceed USD 34.52 billion by 2031 | According to Transparency Market Research Analysis

Global Disposable Gloves Market Size is Estimated to Reach USD 20.1 billion by 2031, Growing at a CAGR of 8.21%: Straits Research

GlobeNewswire

6 months ago

Global Disposable Gloves Market Size is Estimated to Reach USD 20.1 billion by 2031, Growing at a CAGR of 8.21%: Straits Research

United Arab Emirates Smart Manufacturing Market Analysis Showcases Growth Trends and Opportunities up to 2030

GlobeNewswire

6 months ago

United Arab Emirates Smart Manufacturing Market Analysis Showcases Growth Trends and Opportunities up to 2030

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) is largely controlled by institutional shareholders who own 77% of the company

Simply Wall St.

6 months ago

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) is largely controlled by institutional shareholders who own 77% of the company

ALLETE's (NYSE:ALE) Upcoming Dividend Will Be Larger Than Last Year's

Simply Wall St.

6 months ago

ALLETE's (NYSE:ALE) Upcoming Dividend Will Be Larger Than Last Year's

Applied Industrial Technologies' (NYSE:AIT) Shareholders Will Receive A Bigger Dividend Than Last Year

Simply Wall St.

6 months ago

Applied Industrial Technologies' (NYSE:AIT) Shareholders Will Receive A Bigger Dividend Than Last Year

Decoding TE Connectivity Ltd (TEL): A Strategic SWOT Insight

GuruFocus.com

6 months ago

Decoding TE Connectivity Ltd (TEL): A Strategic SWOT Insight

Crypto-Linked Stocks Rise With Bitcoin as Analyst Says 'Not The Time to Turn Bearish'

CoinDesk

6 months ago

Crypto-Linked Stocks Rise With Bitcoin as Analyst Says 'Not The Time to Turn Bearish'

CNX Resources Full Year 2023 Earnings: Beats Expectations

Simply Wall St.

6 months ago

CNX Resources Full Year 2023 Earnings: Beats Expectations

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

PR Newswire

6 months ago

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

UNDER ARMOUR ANNOUNCES THIRD QUARTER FISCAL 2024 EARNINGS CONFERENCE CALL DATE

PR Newswire

6 months ago

UNDER ARMOUR ANNOUNCES THIRD QUARTER FISCAL 2024 EARNINGS CONFERENCE CALL DATE

Coty Inc.'s (NYSE:COTY) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Simply Wall St.

6 months ago

Coty Inc.'s (NYSE:COTY) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Blackstone to acquire Tricon for $3.5 billion

HousingWire

6 months ago

Blackstone to acquire Tricon for $3.5 billion

John Bean (JBT) Hikes Marel Offer, Expects Upbeat '23 Results

Zacks

6 months ago

John Bean (JBT) Hikes Marel Offer, Expects Upbeat '23 Results

H.B. Fuller Company (NYSE:FUL) Q4 2023 Earnings Call Transcript

Insider Monkey

6 months ago

H.B. Fuller Company (NYSE:FUL) Q4 2023 Earnings Call Transcript

4 Stocks to Buy on a Dip

Barrons.com

6 months ago

4 Stocks to Buy on a Dip

H.B. Fuller Co (FUL) Reports Strong Adjusted EBITDA Growth in Q4 and FY 2023

GuruFocus.com

6 months ago

H.B. Fuller Co (FUL) Reports Strong Adjusted EBITDA Growth in Q4 and FY 2023

Is SeaWorld Entertainment (SEAS) Stock Undervalued Right Now?

Zacks

6 months ago

Is SeaWorld Entertainment (SEAS) Stock Undervalued Right Now?

IDEAYA Biosciences Inc President and CEO Yujiro Hata Sells 75,000 Shares

GuruFocus.com

6 months ago

IDEAYA Biosciences Inc President and CEO Yujiro Hata Sells 75,000 Shares

All You Need to Know About Essential Properties (EPRT) Rating Upgrade to Buy

Zacks

6 months ago

All You Need to Know About Essential Properties (EPRT) Rating Upgrade to Buy

IDEAYA Biosciences, Inc. (IDYA) Moves 7.6% Higher: Will This Strength Last?

Zacks

6 months ago

IDEAYA Biosciences, Inc. (IDYA) Moves 7.6% Higher: Will This Strength Last?

16 Best Mid-Cap Growth Stocks To Buy Now

Insider Monkey

6 months ago

16 Best Mid-Cap Growth Stocks To Buy Now

GE Healthcare (GEHC) Buys MIM Software to Boost Imaging Tools

Zacks

6 months ago

GE Healthcare (GEHC) Buys MIM Software to Boost Imaging Tools

BridgeBio Pharma Announces Publication of Positive Results from Phase 3 ATTRibute-CM Study of Acoramidis for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in the New England Journal of Medicine

GlobeNewswire

7 months ago

BridgeBio Pharma Announces Publication of Positive Results from Phase 3 ATTRibute-CM Study of Acoramidis for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in the New England Journal of Medicine

Schneider National, Inc. to Report Fourth Quarter 2023 Earnings on February 1, 2024

Business Wire

7 months ago

Schneider National, Inc. to Report Fourth Quarter 2023 Earnings on February 1, 2024

Is There An Opportunity With ExlService Holdings, Inc.'s (NASDAQ:EXLS) 21% Undervaluation?

Simply Wall St.

7 months ago

Is There An Opportunity With ExlService Holdings, Inc.'s (NASDAQ:EXLS) 21% Undervaluation?

IDEAYA Biosciences Announces Participation at the 42nd Annual J.P. Morgan Healthcare Conference and 2024 Corporate Guidance

PR Newswire

7 months ago

IDEAYA Biosciences Announces Participation at the 42nd Annual J.P. Morgan Healthcare Conference and 2024 Corporate Guidance

Avis Budget Group (CAR) Increases Yet Falls Behind Market: What Investors Need to Know

Zacks

7 months ago

Avis Budget Group (CAR) Increases Yet Falls Behind Market: What Investors Need to Know

Share on Social Networks: